Solid Biosciences, Inc. (SLDB)
6.395
-0.54
(-7.72%)
USD |
NASDAQ |
Feb 11, 16:00
6.46
+0.06
(+1.02%)
After-Hours: 20:00
Solid Biosciences EPS Diluted (Quarterly) : -0.4848 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.613 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.78M |
| Total Expenses (Quarterly) | 45.78M |
| Enterprise Value | 325.71M |
| Earnings Yield | -38.99% |
| Normalized Earnings Yield | -37.30 |